Evidence map›Paper›PMID 40370773›Full record

ArticleFrontiers in endocrinology2025

Biomarkers of GH deficiency identified in untreated and GH-treated Pit-1 mutant mice.

Sarmed Al-Samerria, Huiting Xu, M Elena Diaz-Rubio, Joseph Phelan, Chi Su, Keer Ma, Anna Newen, Kiana Li, Sayaka Yamada, Ariel L Negron and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Blood biomarkers and breed genetics of aging in pet dogs.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sarmed Al-SamerriaDepartment of Pediatrics, University of Arizona College of Medicine, Phoenix, AZ, United States.
Huiting XuDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
M Elena Diaz-RubioRutgers Cancer Institute, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Joseph PhelanDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Chi SuDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Keer MaDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Anna NewenDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Kiana LiDepartment of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Sayaka YamadaDepartment of Medicine, University of Arizona College of Medicine, Phoenix, AZ, United States.
Ariel L NegronDepartment of Pediatrics, University of Arizona College of Medicine, Phoenix, AZ, United States.
Fredric WondisfordDepartment of Medicine, University of Arizona College of Medicine, Phoenix, AZ, United States.
Sally RadovickDepartment of Pediatrics, University of Arizona College of Medicine, Phoenix, AZ, United States.

Funding

TRANSFER: 5U01HD086838-03 Genetic Diagnosis of Childhood Growth DisordersU01HD086838 · NICHD · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI RADOVICK, SALLY · 2017 to 2020
$694k
NICHD NIH HHS U01 HD086838
6 · The paper itself

Abstract

Background: Growth Hormone Deficiency (GHD) is marked by insufficient growth hormone (GH) production, leading to disruptions in growth and metabolism. Its diagnosis is challenging due to the lack of sensitive, specific tests. To address this, we used a novel mouse model with a POU1F1 (Pit-1) gene mutation (K216E). This study aimed to identify metabolic biomarkers of GHD and assess their responsiveness to GH therapy, alongside pathway analysis to uncover disrupted metabolic pathways. Methods: The Pit-1 Results: The assessment of the Pit-1 Conclusion: The Pit-1

Indexed as

BiomarkersGrowth HormoneMutationTranscription Factor Pit-1AnimalsDisease Models, AnimalFemaleMaleMetabolomicsMiceBiomarkersGrowth HormonePou1f1 protein, mouseTranscription Factor Pit-1biomarkersenergy metabolismGH treatmentgrowth hormone deficiency (GHD)metabolomicsPIT-1 mutationsex differences

Identifiers

PMID40370773
PMCPMC12074916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.